Ionis Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IONS research report →
About the company
Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes three key medications: SPINRAZA, prescribed for spinal muscular atrophy (SMA) in both children and adults; TEGSEDI, an injectable treatment targeting polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adult patients; and WAYLIVRA, which addresses familial chylomicronemia syndrome and familial partial lipodystrophy.
- CEO
- Brett Monia
- IPO
- 1991
- Employees
- 1,069
- HQ
- Carlsbad, CA, US
Price Chart
- Market Cap
- $13.52B
- P/E
- -41.11
- P/S
- 12.78
- P/B
- 27.44
- EV/EBITDA
- 3.36
- Div Yield
- 0.00%
- Gross Margin
- 98.35%
- Op Margin
- -33.35%
- Net Margin
- -30.87%
- ROE
- -58.57%
- ROIC
- -11.14%
- Revenue
- $944.00M · 33.87%
- Net Income
- $-381,000,000 · 16.06%
- EPS
- $-2.38 · 21.71%
- Op Income
- $-382,000,000
- FCF YoY
- 41.41%
- 52W High
- $86.74
- 52W Low
- $40.03
- 50D MA
- $75.46
- 200D MA
- $75.75
- Beta
- 0.37
- Avg Volume
- 1.83M
Get TickerSpark's AI analysis on IONS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 26, 26 | Baroldi Joseph | other | 1,769 |
| Jun 26, 26 | Baroldi Joseph | other | 3,866 |
| Jun 26, 26 | Baroldi Joseph | sell | 5,635 |
| Jun 26, 26 | Baroldi Joseph | other | 1,769 |
| Jun 26, 26 | Baroldi Joseph | other | 3,866 |
| Jun 26, 26 | O'NEIL PATRICK R. | sell | 3,069 |
| Jun 26, 26 | Schneider Eugene | other | 26,000 |
| Jun 26, 26 | Schneider Eugene | sell | 26,000 |
| Jun 26, 26 | Schneider Eugene | other | 26,000 |
| Jun 26, 26 | Monia Brett P | other | 50,000 |
Our IONS coverage
Recent articles, reports, and earnings notes.
No research on IONS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IONS report →Similar companies
Peers in the same neighborhood.